Sunshine Heart taps former Cardiovascular Systems exec Brandt for regulatory VP
Sunshine Heart (NSDQ:SSH) said last week it picked former Cardiovascular Systems (NSDQ:CSII) quality and regulatory affairs veep Megan Brandt for its new position of veep of regulatory affairs and quality assurance.
While at Cardiovascular Systems, Brandt facilitated domestic and international clinical study submissions and obtained multiple regulatory approvals, Sunshine Heart said.
“Megan brings to the company a specific set of necessary skills to successfully guide us through the regulatory approval process as we push forward in our new clinical strategy. Her extensive leadership and experience will be critical for the new strategic direction of the company,” CEO John Erb said in prepared remarks.